Deify Health Care Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-10-2024
- Paid Up Capital ₹ 2.02 M
as on 29-10-2024
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 M
as on 29-10-2024
- Satisfied Charges ₹ 1.00 Cr
as on 29-10-2024
- Revenue %
(FY 2023)
- Profit 62.87%
(FY 2023)
- Ebitda 3.69%
(FY 2023)
- Net Worth -0.16%
(FY 2023)
- Total Assets -0.16%
(FY 2023)
About Deify Health Care
The Corporate was formerly known as Ujjwal Biotech Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.02 M.
The company currently has active open charges totaling ₹8.00 M. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishna Goel and Hukam Goel serve as directors at the Company.
- CIN/LLPIN
U74899DL1990PTC041503
- Company No.
041503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deify Health Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Goel  | Director | 24-Jun-2021 | Current |
| Hukam Goel | Director | 24-Jun-2021 | Current |
Financial Performance of Deify Health Care.
Deify Health Care Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.87% increase in profit. The company's net worth dipped by a decrease of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deify Health Care?
In 2023, Deify Health Care had a public holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ujjawal Overseas (India) Private LimitedActive 30 years 21 days
Krishna Goel and Hukam Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 22 Feb 1997 | ₹2.50 M | Open |
Union Bank Of India Creation Date: 21 Feb 1997 | ₹2.50 M | Open |
Union Bank Of India Creation Date: 28 Jan 1997 | ₹1.00 M | Open |
How Many Employees Work at Deify Health Care?
Unlock and access historical data on people associated with Deify Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deify Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deify Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
